Nanshan ZHONG
Inventor
Stats
- 2 US patents issued
- 16 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 2 US Patents Issued
- 16 US Applications Filed
- 7 Total Citation Count
- Jul 11, 2024 Most Recent Filing
- Apr 9, 2013 Earliest Filing
Work History
Inventor Addresses
| Address | Duration |
|---|---|
| Grand Cayman, KY | Jun 22, 17 - Oct 10, 17 |
| Guangzhou City, CN | Mar 01, 18 - May 05, 22 |
| Guangzhou, CN | Oct 03, 13 - Feb 11, 25 |
| Liaoning, CN | Mar 30, 23 - Feb 13, 25 |
| Taipa, MO | Oct 05, 17 - Jul 05, 22 |
| Taipei City, TW | Nov 01, 18 - Oct 24, 19 |
| Taipei, TW | Nov 26, 19 - Nov 26, 19 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A23L: | FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT | 1 |
| A23P: | SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS | 1 |
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 13 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2025/0049,831 | 2025 | ANTIVIRAL USE OF BISEPOXYLIGNAN COMPOUND, AND BISEPOXYLIGNAN COMPOSITION AND PREPARATION OF BISEPOXYLIGNAN COMPOUND | 0 |
| 12220461 | 2025 | Polypeptide-coupled small molecule compound and antiviral application thereof | 0 |
| 2025/0032,485 | 2025 | APPLICATION OF IMIDAZO [1,2-A] PYRAZINE COMPOUNDS OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS IN THE PREPARATION OF ANTI-CORONAVIRUS DRUGS | 0 |
| 2024/0382,604 | 2024 | POLYPEPTIDE-COUPLED SMALL MOLECULE COMPOUND AND ANTIVIRAL APPLICATION THEREOF | 0 |
| 12144789 | 2024 | Pharmaceutical composition exhibiting anti-tumor activity, method for treating patient suffering from cancer and method for inhibiting tumor growth | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.